LUXSOL(TM) Topical Cream for the Treatment of Symptomatic Bacterial Vaginosis; A Proof of Concept Study
An Open-Label, Randomized Study to Determine the Safety and Efficacy of LUXSOL(TM) Cream for the Treatment of Bacterial Vaginosis: A Proof of Concept Study
Sponsor: CDA Research Group, Inc.
Terminated
Not for safety reasons
Other terminated trials from CDA Research Group, Inc.
More terminations from CDA Research Group, Inc.
This EARLY_PHASE1 trial investigates Bacterial Vaginosis (BV) and is currently terminated or withdrawn. CDA Research Group, Inc. leads this study, which shows 7 recorded versions since 2014 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated EARLY_PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Terminated EARLY_PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Terminated EARLY_PHASE1
-
May 2018 — Jun 2018 [monthly]
Terminated EARLY_PHASE1
Status: Suspended → Terminated
▶ Show 2 earlier versions
-
Feb 2017 — May 2018 [monthly]
Suspended EARLY_PHASE1
Phase: Phase 0 → EARLY_PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Suspended Phase 0
First recorded
Jun 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CDA Research Group, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .